The bystander effect mediated by the new murine gammaherpesvirus 72-thymidine kinase/5'-fluoro-2'-deoxyuridine (MHV72-TK/5-FUdR) system in vitro

Antiviral Chemistry and Chemotherapy

Volumn 11, Issue 4, 2000, Pages 273-282

  Raslova, Hana ^a,b   Matis, Jan ^a   Rezuchova, Ingeborg ^a   Macakova, Katarina ^a   Berebbi, Monique ^b   Kudelova, Marcela ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b Institute de Recherche sur le Cancer   (France)

Author keywords

5' Fluoro 2' deoxyuridine.; Antiviral; Gammaherpesvirus; Ganciclovir; Kinase; MHV 72; Thymidine

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; FLOXURIDINE; GANCICLOVIR; THYMIDINE KINASE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CELL KILLING; DRUG SENSITIVITY; ENZYME ACTIVITY; EXPRESSION VECTOR; FIBROBLAST CULTURE; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SUICIDE GENE; SURVIVAL RATE;

EID: 0033864765     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020001100403     Document Type: Article

References (54)

1. Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Shimizu K & Seno T (1987) Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. Molecular Pharmacology 32:410-416.
2. Balzarini J, Bohman C & De Clercq E (1993) Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. Journal of Biological Chemistry 268:6332-6337.
3. Blaskovic D, Stancekova M, Svobodova J (Mistrikova J (1980) Isolation of five strains of herpesviruses from two species of free-living small rodents. Acta Virologica 24:468.
4. Black ME, Newcomb TG, Wilson HMP & Loeb LA (1996) Creation of drug-specific herpes simplex virus type A thymidine kinase mutants for gene therapy. Proceedings of the National Academy of Sciences, USA 93:3525-3529.
5. Boucher PD, Ruch RJ & Schewach DS (1998) Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase. Human Gene Therapy 9:801-814.
6. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL & Klatzmann D (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proceedings of the National Academy of Science, USA 90:7024-7028.
7. Cazaux CH, Tiraby M, Loubiere L Haren L, Klatzmann D & Tiraby G (1998) Phosphorylation and cytotoxicity of therapeutic nucleoside analogues: A comparison of and herpesvirus thymidine kinase suicide genes. Cancer Gene Therapy 5:83-91.
8. Chen ChY, Chang YN, Ryan P, Linscott M, McGarrity GJ & Chiang YL (1995) Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the 'bystander effect'. Human Gene Therapy 6:1467-1476.
9. Chen L, Chen D, Manome Y, Dong Y, Fine HA & Kufe DW (1995) Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. Journal of Clinical Investigation 96:2775-2782.
10. Chen C & Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Molecular Cell Biology 7:2745-2752.
11. Coll JL, Mesnil M, Lefebre MF, Lancon A & Favrot MC (1997) Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments. Gene Therapy 4:1160-1166.
12. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH & Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC) 256:1550-1552.
13. De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS & Walker RT (1979) (E)-5-(2-Bromovinyl)-2′-deoxyuridine: a potent and selective anti-herpes agent. Proceedings of the National Academy of Science, USA 76:2947-2951.
14. Efstathiou S, Ho YM & Minson AC (1990a) Cloning and molecular characterization of the murine herpesvirus 68 genome. Journal of General Virology 71:1355-1364.
15. Efstathiou S, Ho YM, Hall S, Styles CJ, Scott SD & Gompels UA (1990b) Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. Journal of General Virology 71:1365-1372.
16. Ezzedine ZD, Martuza RL, Platika D, Short MP, Malick A, Choi B & Breakefield XO (1991) Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biologist 3:608-614.
17. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL & Abraham GN (1993) The 'bystander effect': Turnor regression when a fraction of the tumor mass is genetically modified. Cancer Research 53:5274-5283.
18. Gardella T, Medveczky P, Sairenji T & Mulder C (1984) Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. Journal of Virology 50:248-254.
19. Grignet-Debrus C & Calberg-Bacq CM (1997) Potencial of varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells. Gene Therapy 4:560-569.
20. Gustafson EA, Chillemi AC, Sage DR & Fingeroth JD (1998) The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrobial Agents and Chemotherapy 42:2923-2931.
21. Hayashi S, Emi N, Yokoyama I, Uchida K & Tagaki H (1997) Effect of gene therapy with the herpes simplex virus-thymidine kinase gene on hepatic metastasis in murine colon cancer. Surgery Today 27:40-43.
22. Herbst JS, Morgan J, Raab-Traub N & Resnick L (1989) Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. Journal of the American Academy of Dermatology 21:753-756.
23. Ishii-Morita H, Agbaria R, Mullen CA, Hirano H, Koeplin DA, Ram Z, Oldfield EH, Johns DG & Blaese RM (1997) Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Therapy 4:244-251.
24. Kitchens ME, Forsthoefel AM, Rafique Z, Spencer HT & Berger FG (1999) Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation. Journal of Biological Chemistry 274:12544-12547.
25. Kokoris MS, Sabo P, Adam ET & Black ME (1999) Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Therapy 6:1415-1426.
26. Koyano S, Suzutani T, Yoshida I & Azuma M (1996) Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. Antimicrobial Agents and Chemotherapy 40:920-923.
27. Lin JC, Nelson DJ, Lambe CU & Choi EI (1986) Metabolic activation of 9-[2-hydroxy-1-(hydroxymethyl)methyl]guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus. Journal of Virology 60:569-573.
28. Link CJJ, Levy JP, McCann LZL & Moorman DW (1997) Gene therapy for colon cancer with herpes simplex thymidine kinase gene. Jornal of Surgical Oncology 64:289-294.
29. Littler E, Stuart AD & Chee MS (1992) Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
30. Maniatis T, Fritsch EF & Sambrook J (1982) Molecular cloning - α laboratory manual. Cold Spring Harbor Laboratory.
31. Marcel T & Grausz JD (1997) The TMC worldwide gene therapy enrollment report end 1996. Human Gene Therapy 8:775-800.
32. Mistrikova J, Remenova A, Lesso J & Stancekova M (1994) Replication and persistence of murine herpesvirus 72 in lymphatic system and peripheral blood mononuclear cells of BALB/c mice. Acta Virologica 38:151-156.
33. Mistrikova J, Rajcani J, Mrmusova M & Oravcova I (1996a) Chronic infection of BALB/c mice with murine herpesvirus 72 is associated with neoplasm development. Acta Virologica 40:297-301.
34. Mistrikova J, Furdikova D, Oravcova I & Rajcani J (1996b) Effect of immunosupression on BALB/c mice infected with the mouse herpesvirus (MHV72). Acta Virologica 40:41-44.
35. Newman C & Polk BF (1987) Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanin (DHPG). Annals of Internal Medicine 107:348-350.
36. Neyts J & de Clercq E (1998) In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents. Antimicrobial Agents and Chemotherapy 42:170-172.
37. Patel VD, Nolan RS, Hu N, Clark EB, Hootnick DR, Levinsohn EM & Packard DS (1996) Embryonic hypertension following exposure to teratogenic doses of 5-fluoro-2′-deoxyuridine. Biomedical Environmental Science 9:408-417.
38. Pepper S de V, Stewart JP, Arrand JR & Mackett M (1996) Murine gammaherpesvirus-68 encodes homologues of thymidine kinase and glycoprotein H: Sequence, expression, and characterization of pyrimidine kinase activity. Virology 219:475-479.
39. Ram Z, Culver KW, Wallbridge S, Blease RM & Oldfield EH (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Research 53:83-88.
40. Reichel M, Matis J, Mistrikova J & Lesso J (1994) The analysis of polypeptides in the nuclei and cytoplasm of cells infected with murine herpesvirus 72. Journal of General Virology 75:1259-1265.
41. Roth JA & Cristiano RJ (1997) Gene therapy for cancer: What have we done and where are we going? Journal of the National Cancer Institute 89:21-39.
42. Rubsam LZ, Boucher PD, Murphy PJ, KuKuruga M & Shewach DS (1999) Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells coculrured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells. Cancer Research 59:669-675.
43. Simas JP & Efstathiou S (1998) Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends in Microbiology 6:276-282.
44. Smee DF, Burger RA, Warren RP, Bailey KW & Sidwell RW (1997) An immunosupressed mouse model of lethal murine gammaherpesvirus 68 infection for studying potential treatment of Epstein-Barr virus infection in man. Antiviral Chemistry & Chemotherapy 8:573-581.
45. Smith RF & Smith TF (1989) Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella zoster virus, and Epstein-Barr virus. Journal of Virology 63:450-455.
46. Sunil-Chandra NP, Efstathiou S & Nash AA (1992) Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. Journal of General Virology 73:3275-3279.
47. Sunil-Chandra NP, Arno J, Fazarkerley J & Nash AA (1994a) Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. American Journal of Pathology 145:818-826.
48. Sunil-Chandra NP, Efstathiou S & Nash AA (1994b) The effect of acyclovir on the acute and latent murine gammaherpesvirus-68 infection of mice. Antiviral Chemistry & Chemotherapy 5:290-296.
49. Touraine RL, Ishii-Morita H, Ramsey WJ & Blaese RM (1998) The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication. Gene Therapy 5:1705-1711.
50. Van Laar JA, Van der Wilt CL, Rustum YM, Noordhuis P, Smid K, Pinedo HM & Peters GJ (1996) Therapeutics efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model. Clinical Cancer Research 2:1327-1333.
51. Ville RG & Hart IR (1993) Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibite growth of established murine melanomes following direct intratumoral injection of DNA. Cancer Research 53:5860-3864.
52. Virgin IV HW, Latreille P, Wamsley P, Hallsworth K, Week KE, Dal Canto AJ & Speck SH (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. Journal of Virology 71:5894-5904.
53. Washtien WL & Santi DV (1979) Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorourail. Cancer Research 39:3397-404.
54. Yamada M, Nakagawa H, Fukushima M, Shimizu K, Hayakawa T & Ikenaka K (1998) In vitro study on intrathecal use of 5-fluoro-2′-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain rumors. Journal of Neurooncology 37:115-121.